Literature DB >> 2087265

Effects of iontophoretically applied monoamines on somatosensory cortical neurons of unanesthetized rats.

M H Bassant1, K Ennouri, Y Lamour.   

Abstract

The response of somatosensory cortical neurons to iontophoretic applications of monoamines was studied in unanesthetized rats. The animal's head was held in a stereotaxic apparatus by means of a painless head-restraining system implanted 8 days prior to the recording sessions. The electrodes consisted of a recording micropipette attached to a multibarreled iontophoresis micropipette. The electrode penetrations were reconstructed on camera lucida drawings of frontal brain sections. The percentage of cortical neurons responding to application of monoamines were 76% after noradrenaline, 58% after dopamine and 66% after serotonin. The differences observed among percentages of responses seemingly correlate with the relative abundance of terminal axons and receptors for each of the three monoamines in the somatosensory cortex. The vast majority of the responding neurons were inhibited by monoamines and this inhibitory effect was independent of the level of spontaneous activity. The depressant effect of the monoamines on glutamate and acetylcholine-evoked responses supports a modulatory role for these substances. Serotonin was the most potent, followed by noradrenaline and dopamine. The present study shows that when the influence of anesthesia is eliminated, the predominant effect of monoamines on cortical first somatosensory neurons is one of inhibition. These findings contrast with results obtained under some anesthetic conditions, as well as under in vitro conditions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2087265     DOI: 10.1016/0306-4522(90)90279-d

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  12 in total

1.  Stimulus-specific effects of noradrenaline in auditory cortex: implications for the discrimination of communication sounds.

Authors:  Quentin Gaucher; Jean-Marc Edeline
Journal:  J Physiol       Date:  2014-12-18       Impact factor: 5.182

Review 2.  The thalamo-cortical auditory receptive fields: regulation by the states of vigilance, learning and the neuromodulatory systems.

Authors:  Jean-Marc Edeline
Journal:  Exp Brain Res       Date:  2003-09-27       Impact factor: 1.972

3.  Sensory responses of neurons in the medial septal area in conditions of modulation of theta activity using the alpha-2-adrenoreceptor agonist clonidine.

Authors:  V F Kichigina; E S Kutyreva; V V Sudnitsyn
Journal:  Neurosci Behav Physiol       Date:  2005-01

4.  Comparative roles of acetylcholine and noradrenaline in controlling the spontaneous activity of cortical neurons.

Authors:  A V Isakova; Yu S Mednikova
Journal:  Neurosci Behav Physiol       Date:  2007-09

5.  The alpha 2-adrenergic antagonist idazoxan enhances the frequency selectivity and increases the threshold of auditory cortex neurons.

Authors:  J M Edeline
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

Review 6.  Mechanisms underlying gain modulation in the cortex.

Authors:  Katie A Ferguson; Jessica A Cardin
Journal:  Nat Rev Neurosci       Date:  2020-01-07       Impact factor: 34.870

7.  Serotonin differentially modulates responses to tones and frequency-modulated sweeps in the inferior colliculus.

Authors:  L M Hurley; G D Pollak
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

8.  Noradrenergic excitation and inhibition of GABAergic cell types in rat frontal cortex.

Authors:  Y Kawaguchi; T Shindou
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

Review 9.  Cortical reorganization after spinal cord injury: always for good?

Authors:  K A Moxon; A Oliviero; J Aguilar; G Foffani
Journal:  Neuroscience       Date:  2014-07-02       Impact factor: 3.590

10.  Beyond traditional approaches to understanding the functional role of neuromodulators in sensory cortices.

Authors:  Jean-Marc Edeline
Journal:  Front Behav Neurosci       Date:  2012-07-30       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.